Attitudes towards HPV Vaccination Policy Strategies to Improve Adolescent Vaccination Coverage among Pediatric Providers in New York State

Author:

Shaw Jana1ORCID,Hanley Samantha2,Sitnik Elana2,Berry Winter3,Blatt Steven3,Seserman Michael4,Formica Margaret K.25

Affiliation:

1. Department of Pediatrics, Division of Infectious Diseases, Upstate Golisano Children’s Hospital, SUNY Upstate Medical University, Syracuse, NY 13201, USA

2. Department of Public Health and Preventive Medicine, SUNY Upstate Medical University, Syracuse, NY 13201, USA

3. Department of Pediatrics, Division of General Pediatrics, Upstate Pediatric and Adolescent Center, SUNY Upstate Medical University, Syracuse, NY 13201, USA

4. American Cancer Society, Northeast Region, One Penny Lane, Latham, NY 12110, USA

5. Department of Urology, SUNY Upstate Medical University, Syracuse, NY 13201, USA

Abstract

Pediatric providers’ stances on HPV vaccination-related policies are largely unknown. To gain insight into pediatric providers’ perspectives and potential recommendations for directed policy, we conducted a cross-sectional survey of the American Academy of Pediatrics members in New York. Almost all providers expressed confidence in discussing the HPV vaccine with patients (98.6%, n = 72). Among common barriers to vaccination, providers listed parental safety concerns (n = 60, 82.2%), vaccination not being required for school entry (n = 59, 80.8%), and moral opposition to vaccination (n = 48, 65.8%). Among all respondents, 29 (39.7%), 13 (17.8%), and 2 (2.7%) agreed the vaccine should be required for middle, high, and tertiary school entry, respectively. Support for pharmacist-provision of the vaccine varied, with 31 (42.5%) providers expressing support. Most providers supported adolescent self-consent to vaccination, (n = 67, 91.8%). Providers continued to encounter barriers to HPV vaccination and indicated support of HPV vaccination mandates for school entry, pharmacist provision of the vaccine, and adolescent self-consent to vaccination.

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference32 articles.

1. (2023, June 08). Human Papillomavirus (HPV) Vaccines—NCI, Available online: https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet.

2. National Vaccination Coverage among Adolescents Aged 13–17 Years—National Immunization Survey-Teen, United States, 2021;Pingali;MMWR Morb. Mortal. Wkly. Rep.,2022

3. Prevalence of Cervical Disease at Age 20 after Immunisation with Bivalent HPV Vaccine at Age 12–13 in Scotland: Retrospective Population Study;Palmer;BMJ,2019

4. Estimated Number of Cases of High-Grade Cervical Lesions Diagnosed Among Women—United States, 2008 and 2016;McClung;MMWR Morb. Mortal. Wkly. Rep.,2019

5. The Projected Timeframe until Cervical Cancer Elimination in Australia: A Modelling Study;Hall;Lancet Public Health,2019

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3